Poradosu Enrique 4
4 · Nuvectis Pharma, Inc. · Filed Mar 28, 2023
Insider Transaction Report
Form 4
Poradosu Enrique
Chief Science & Business Off
Transactions
- Purchase
Common Stock
2023-03-27$11.55/sh+500$5,775→ 1,373,819 total
Footnotes (1)
- [F1]Includes 48,399 shares of restricted stock and 175,000 restricted stock units.